#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1099879	B	Inhibition of GCS by cell-based assay		13	ALA1154826	cell-based format	Scientific Literature
2.	ALA1099880	B	Inhibition of sucrase by HPLC		13	ALA1154826	single protein format	Scientific Literature
3.	ALA1099881	B	Inhibition of maltase by HPLC		13	ALA1154826	single protein format	Scientific Literature
4.	ALA1099882	B	Inhibition of lactase by HPLC		13	ALA1154826	single protein format	Scientific Literature
5.	ALA1099883	B	Inhibition of GBA1 by HPLC		13	ALA1154826	assay format	Scientific Literature
6.	ALA1099884	B	Inhibition of GBA2 by HPLC		12	ALA1154826	single protein format	Scientific Literature
7.	ALA1099885	B	Inhibition of lysosomal alpha-glucosidase by HPLC		13	ALA1154826	single protein format	Scientific Literature
8.	ALA1099886	B	Inhibition of glycogen glycogen de-branching enzyme by HPLC		12	ALA1154826	single protein format	Scientific Literature
9.	ALA1099887	F	Antidiabetic activity in obese, insulin resistant C57BL/6J mouse assessed as reduction in plasma glycosphingolipids at 100 mg/kg/day for 4 weeks	Mus musculus	3	ALA1154826	organism-based format	Scientific Literature
10.	ALA1102429	A	Cmax in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
11.	ALA1102430	A	Dose normalized Cmax in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
12.	ALA1102431	A	Half life in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
13.	ALA1102432	A	AUC (infinity) in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
14.	ALA1102433	A	Dose normalized AUC (infinity) in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
15.	ALA1102434	A	Bioavailability in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
16.	ALA1102435	A	Mean residence time in ZDE/Crl-leprfa rat at 3 mg/kg, iv	Rattus norvegicus	2	ALA1154826	organism-based format	Scientific Literature
17.	ALA1102436	F	Antidiabetic activity in obese, insulin resistant C57BL/6J mouse assessed as reduction in liver glycosphingolipids at 100 mg/kg/day for 4 weeks	Mus musculus	2	ALA1154826	organism-based format	Scientific Literature
18.	ALA1102437	F	Antidiabetic activity in ZDF rat assessed as reduction in plasma glycosphingolipids at 20 to 100 mg/kg/day for 4 weeks	Rattus norvegicus	3	ALA1154826	organism-based format	Scientific Literature
19.	ALA1102438	F	Antidiabetic activity in ZDF rat assessed as reduction in liver glycosphingolipids at 20 to 100 mg/kg/day for 4 weeks	Rattus norvegicus	3	ALA1154826	organism-based format	Scientific Literature
20.	ALA1102439	F	Antidiabetic activity in ZDF rat assessed as improvement in blood glucose concentration at 20 to 100 mg/kg/day for 4 weeks	Rattus norvegicus	3	ALA1154826	organism-based format	Scientific Literature